![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
"Updated views on autologous hematopoietic stem cell transplantation for treatment of multiple sclerosis." Expert Review of Neurotherapeutics, 16(5), pp. 469–470
Financial & competing interests disclosure
MP Sormani received consultation fees from TEVA, Novartis, Biogen, Roche, Genzyme, Merck and Vertex. P Muraro declares honoraria for speaking and travel support from Merck Serono, Biogen, Bayer, and Novartis. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Additional information
Notes on contributors
Maria Pia Sormani
